R W Finberg Selected Research

Antiviral Agents (Antivirals)

1/2021

High-throughput human primary cell-based airway model for evaluating influenza, coronavirus, or other respiratory viruses in vitro.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

R W Finberg Research Topics

Disease

4	Infections 01/2021 - 01/2000
3	Abscess 12/2000 - 01/2000
1	Human Influenza (Influenza) 01/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Coronavirus Infections 01/2021
1	Gram-Negative Bacterial Infections 11/2001
1	B-Cell Lymphoma (Lymphoma, B Cell) 09/2001
1	Lymphoma (Lymphomas) 09/2001
1	Bacterial Infections (Bacterial Infection) 03/2000
1	Shock 02/2000
1	Sepsis (Septicemia) 02/2000

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2000
2	Bacterial PolysaccharidesIBA 12/2000 - 03/2000
2	Polysaccharides (Glycans)IBA 03/2000 - 01/2000
1	camostatIBA 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	Peptide Hydrolases (Proteases)FDA Link 01/2021
1	Toll-Like Receptor 4IBA 11/2001
1	AntigensIBA 09/2001
1	Viral AntigensIBA 09/2001
1	Monoclonal AntibodiesIBA 05/2000
1	CD55 Antigens (Decay Accelerating Factor)IBA 05/2000
1	Peptides (Polypeptides)IBA 03/2000
1	Lysine (L-Lysine)FDA Link 03/2000
1	Biological ProductsIBA 03/2000
1	PolymersIBA 03/2000
1	Aspartic Acid (Aspartate)FDA Link 03/2000
1	LipopolysaccharidesIBA 02/2000
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2000

Therapy/Procedure

1	Liver Transplantation 04/2013